abstract |
FIELD: medicine.SUBSTANCE: invention refers to medicine, and concerns using compound of 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol orally for treating melanoma B16, Ehrlich tumors, sarcoma 180, sarcoma 37, lymphosarcoma LIO-1 and carcinosarcoma Walker 256 experimentally in mice and rats.EFFECT: invention extends range of agents for treating malignant tumors.1 cl, 9 ex, 14 dwg, 22 tbl |